Goldman Sachs’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.8M | Sell |
|
|||||
|
2025
Q1 | $11.1M | Buy |
|
|||||
|
2024
Q4 | $15.1M | Sell |
|
|||||
|
2024
Q3 | $17.1M | Buy |
|
|||||
|
2024
Q2 | $18.5M | Sell |
|
|||||
|
2024
Q1 | $19M | Buy |
|
|||||
|
2023
Q4 | $7.32M | Buy |
|
|||||
|
2023
Q3 | $509K | Buy |
|
|||||
|
2023
Q2 | $994K | Buy |
|
|||||
|
2023
Q1 | $684K | Buy |
|
|||||
|
2022
Q4 | $626K | Sell |
|
|||||
|
2022
Q3 | $1.44M | Sell |
|
|||||
|
2022
Q2 | $1.61M | Buy |
|
|||||
|
2022
Q1 | $2.4M | Sell |
|
|||||
|
2021
Q4 | $3.03M | Sell |
|
|||||
|
2021
Q3 | $4.39M | Buy |
|
|||||
|
2021
Q2 | $4.59M | Sell |
|
|||||
|
2021
Q1 | $21.7M | Sell |
|
|||||
|
2020
Q4 | $35.7M | Buy |
|
|||||
|
2020
Q3 | $3.63M | Sell |
|
|||||
|
2020
Q2 | $3.41M | Buy |
|
|||||
|
2020
Q1 | $480K | Sell |
|
|||||
|
2019
Q4 | $1.93M | Buy |
|
|||||
|
2019
Q3 | $993K | Sell |
|
|||||
|
2019
Q2 | $2.32M | Buy |
|